Let-7a/cMyc/CCAT1/miR-17–5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Pathology and Forensic Medicine
Reference60 articles.
1. Why natural killer cells in triple negative breast cancer?;Abdel-Latif;World J. Clin. Oncol.,2020
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
3. BRCA1 and BRCA2 truncating mutations and variants of unknown significance in Egyptian female breast cancer patients;AbdelHamid;Clin. Chim. Acta,2021
4. Long non-coding RNA and breast cancer;Zhang;Technol. Cancer Res Treat.,2019
5. Molecular classification of breast cancer: a retrospective cohort study;Al-Thoubaity;Ann. Med Surg.,2020
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma;Communications Biology;2024-07-06
2. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma;Translational Oncology;2024-07
3. Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma;Non-coding RNA Research;2024-06
4. MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions;Non-coding RNA Research;2024-06
5. LncRNAs in Immune and Stromal Cells Remodel Phenotype of Cancer Cell and Tumor Microenvironment;Journal of Inflammation Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3